Meet the tumor immunology, cell engineering and multi-omics teams of San Diego's research ecosystem at the ImmunoMark launch edition, February 10–11, 2027.
Sponsor San Diego 2027
Our sponsorship team replies within one working day.
Trusted by sponsors from our London 2026 launch edition

If you supply research tools, reagents, cell and animal models or preclinical CRO services, ImmunoMark Summit is a cancer conference San Diego research teams can reach in a short drive, and a launch edition where your brand can set the tone.
San Diego’s cancer research runs on a dense mix of academic institutes and venture-backed biotech, much of it on and around Torrey Pines Mesa. The ImmunoMark agenda describes the city as one of the world’s leading biotechnology and life sciences hubs, and the West Coast edition is built to draw on that base. It runs February 10–11, 2027, with 300+ senior delegates expected across two parallel streams: Immuno-Oncology, and Biomarkers, Companion Diagnostics & Precision Medicine.
For a supplier, the useful feature is the overlap. Both streams lean heavily on preclinical and translational science, so the scientists who choose models, reagents and instruments sit in the same sessions as the heads of translational medicine who approve spend. The prospectus puts 55–60% of delegates in biotech and pharma, 10–15% in academic and research roles, and 45–50% in senior leadership.
Real sessions from the San Diego 2027 agenda, grouped by the research teams they draw and the products those teams buy.
| Research buyer group | What they buy | Sessions that draw them |
|---|---|---|
| Cell engineering and in vivo CAR teams | Vectors, gene-editing reagents, primary cells, potency and functional assays | The Future of In Vivo Cell Engineering and Gene Editing Technologies in Cancer Immunotherapy (Day 1, Stream 1); Emerging NK Cell, TIL and In Vivo CAR Platforms Reshaping Cancer Immunotherapy (Day 2, Stream 1) |
| Tumor immunology and resistance labs | Syngeneic and humanized models, immune-profiling panels, antibodies, preclinical studies | Overcoming Resistance Mechanisms to Improve Long-Term Responses to Immunotherapy (Day 2, Stream 1); Harnessing the Human Microbiome to Enhance Immunotherapy Response and Patient Outcomes (Day 2, Stream 1) |
| RNA and synthetic biology groups | Oligos, RNA synthesis, editing tools, screening services | RNA Therapeutics and Gene Editing Technologies for Next-Generation Cancer Treatments (Day 2, Stream 1); Synthetic Biology Approaches for Engineering the Next Generation of Cancer Therapeutics (Day 1, Stream 1) |
| Multi-omics, spatial and single-cell cores | Single-cell and spatial platforms, mass spectrometry, sample prep and reagents | Leveraging Multi-Omics Technologies to Identify Predictive Biomarkers for Precision Oncology (Day 1, Stream 2); Beyond Spatial Omics: Multimodal Measurement as Infrastructure for Precision Medicine (Day 1, Stream 2, Ivan Lebedev, Verdant Center for Spatial Biology); Single-Cell Technologies and Functional Biomarkers Driving the Future of Precision Oncology (Day 2, Stream 2) |
| Computational immunology teams | AI and analysis platforms, data services, compute | Computational Immunology and Digital Twin Technologies for Precision Cancer Treatment (Day 1, Stream 1); Decoding Response and Resistance to Immunotherapy in NSCLC Through Integrative Multi-Omic and AI Approaches (Day 1, Stream 2, Ariel (Yung-Chia) Chen, Johnson & Johnson) |
The speaker faculty shows the bench-level seniority you can expect. It includes Emel Esen, Senior Principal Scientist, Translational Medicine at Genentech; Mira Tohme, Associate Director/Principal Scientist, Translational Medicine at Nkarta, Inc.; Ravindra Gujar, Senior Scientist, Immuno-oncology at Onchilles Pharma; Shruti Yadav, Senior Scientist at EpiBiologics; and Santosh A. Misal, Staff Scientist and Manager of the Mass Spectrometry Facility at the National Institute of Allergy and Infectious Diseases (NIAID). These are the people who write the methods section and specify the reagents in it, which makes this a cancer immunology conference San Diego suppliers can sell into directly.
Launch editions carry less history, and that cuts both ways. For a research supplier the upside is visibility that later editions will not offer at the same level.
At the cancer conference San Diego 2027 launch, sponsors are the names on the first program, the on-site signage and the post-event report, and the first suppliers this audience links with the summit.
The format is tested. Research suppliers including PromoCell, Miltenyi Biotec and Hologic Diagenode took part in London 2026, where sponsors held 15–25 meetings each.
For suppliers with a Southern California field team, two days of booked meetings can cover accounts that would otherwise take weeks of site visits, and client passes let you host existing customers.
Research buyers judge a supplier on data. Pick a package with a Day 1 talk to present it, meetings to turn interest into trials, and a stand for demonstrations. Every tier includes the delegate list with contact details and post-event branding.
Platinum slots on Day 1 sit among the cell engineering and tumor microenvironment sessions, where your model, reagent or editing data lands with the right scientists.
For local reagent and consumables suppliers who want a presence and the delegate list for follow-up.
Exclusive to one company: host the Day 1 reception, 6:00 to 7:00 p.m., in your home city.
Omics, spatial and single-cell vendors may prefer Platinum or Gold in the Biomarkers, Companion Diagnostics & Precision Medicine stream instead. Gold gives 6 meetings and a 30-minute Day 2 talk before lunch. Compare every option on the San Diego sponsorship page.
Estimate what ten meetings with translational and discovery leads are worth to your pipeline.
Open the ROI calculatorHow you staff a cancer research conference San Diego hosts depends on where your team sits. Two common set-ups:
Related pages: for immune-monitoring and cell-therapy tools, see the cancer immunotherapy view of San Diego; for discovery biomarker tools reaching labs across the state, the California oncology biomarker page. If you sell into European labs too, the London research suppliers page covers the March edition. For context on one of the Day 1 and Day 2 Stream 1 themes, read our piece on in vivo CAR-T. Of the cancer conferences California research suppliers weigh each year, this is the one built around booked conversations.
Get the San Diego prospectus and see which stream slots remain.
Request the prospectusPick a package, add your own numbers and see the pipeline it creates. London 2026 sponsors averaged 15 to 25 meetings each, with 70% senior decision-makers in the room.
1. Choose a package
2. Your numbers
Year-one value of a new pharma or biotech customer
Booth visits, networking and questions after your talk
Share of conversations worth a proposal
Your typical close rate
Sponsorship plus travel and team costs
expected first-year revenue for every $1 of your event budget
Estimates only, based on the numbers you enter. Meetings and inclusions from the San Diego 2027 sponsorship prospectus. 1:1 meetings are pre-scheduled with delegates you choose from the attendee list.
What sponsors said
Here is what sponsors told us at our London 2026 launch edition.
We really liked the focus of the event, the topics, the talks, really good opportunity to engage with people, the support we get from you is really great and we appreciate that very much. Based on our experience we would be very interested in also sponsoring the next annual event.

We are always interested in sponsoring interesting conference, based on this years experience, I guess I will manage to get some budget for the next edition.

Conversations I have had are very high level, the footfalls been great and the kind of research going on around is really life changing. We will be very interested in sponsoring the second annual.

My experience here at Immunomark 2026 has been really great. We benefit from very good logistical organisation. Networking sessions were excellent and we consider Immunomark a strategic conference for the coming years.

We got the occasion to discuss customer projects and understand their needs better and how we can help them.

The conference has been great so far with strong interactions at the booth and excellent attendance at our talk. We will definitely think about the next edition.

Quality of the talks were really nice and the attendee list had experts from biotech pharma field. It was great meeting everyone and we look forward to positive outcomes.

The talks have been really interesting so far with a great combination of researchers and clinicians. Moderators encouraged excellent discussions.

The program draws cell engineering and in vivo CAR teams, tumor immunology and resistance labs, RNA and synthetic biology groups, multi-omics and single-cell cores, and computational immunology teams. The prospectus puts 55–60% of delegates in biotech and pharma, 10–15% in academic and research roles and 45–50% in senior leadership.
The format has been tested in London, where the 2026 edition drew 300+ delegates from 100+ companies and sponsors held 15–25 meetings each, with research suppliers such as PromoCell, Miltenyi Biotec and Hologic Diagenode taking part. San Diego expects 300+ senior delegates, and launch sponsors get visibility later editions cannot repeat.
Model, reagent, cell engineering and gene-editing suppliers usually fit the Immuno-Oncology stream. Single-cell, spatial, mass spectrometry and multi-omics vendors usually fit the Biomarkers, Companion Diagnostics & Precision Medicine stream. Platinum, Gold and Silver sponsors choose one stream for their talk; meetings are chosen from the full delegate list.
Yes. Packages include client passes alongside your team passes: 10 with Headline, 8 with Platinum, 6 with Gold, 4 with Silver and 2 with Exhibitor. Hosting a current customer lets prospects hear about your products from a peer.
Yes. The drinks reception sponsorship is exclusive to one company. It includes a 5-minute welcome speech, your logo on all invitations, roll-up banners in the networking area and 2 passes. The reception runs from 6:00 to 7:00 p.m. at the end of Day 1, February 10.
Tell us who you want to meet. We will send the prospectus, current package availability and a recommendation within one working day.